Crane Company (CR) Stock Forecast & Price Target

Crane's positive outlook is underscored by a robust 5.6% year-over-year increase in total organic sales, driven by significant demand within its cryogenic and power businesses, particularly fueled by the expanding data center infrastructure. The company's total backlog reached $1.44 billion, reflecting a 16% increase and showcasing strength in core orders, which grew nearly 2% year-over-year. Furthermore, Crane is well-positioned for future growth with opportunities stemming from its involvement in key defense and aerospace initiatives, alongside increased demand driven by reshoring in the pharmaceutical sector, reinforcing its competitive advantages and financial flexibility.

Crane's stock outlook is negatively influenced by stagnating performance in its process flow technologies (PFT) segment, where organic sales declined by 1.5% in the fourth quarter of 2025 and a cautious demand environment led to a 4% decrease in inbound organic orders year-over-year. Despite a solid 12.8% growth in the aerospace and advanced technologies segment, overall demand trends, particularly within the chemical business in Europe and Asia-Pacific, have raised concerns and tempered expectations for core growth in 2026. Additionally, the company's guidance for fourth-quarter earnings per share was below both internal models and consensus estimates, indicating potential operational challenges and a more pessimistic financial outlook ahead.